Synapse - Efsevia Vakiani

Results (265)

KRAS and BRAF: Drug targets and predictive biomarkers

Journal Article

Vakiani, E.; Solit, D. B.
Journal of Pathology (2011)

Grade progression of well differentiated neuroendocrine tumors (WDNETs) of the enteropancreatic system is distinct from poorly differentiated (PD) high grade neuroendocrine carcinomas (PDHGNECas)

Meeting Abstract

Tang, L. H.; Song, L.; Shia, J.; Vakiani, E.; Klimstra, D. S.
Laboratory Investigation (2010)

Fulltext@MSK | Save

Discordance between MSI-H histology and DNA hismatch repair (MMR) protein immunohistochemistry (IHC) in colorectal carcinoma of young patients: frequency and clinical significance

Meeting Abstract

Shia, J.; Sempoux, C.; Tang, L.; Katabi, N.; Vakiani, E.; Guo, M.; Weiser, M.; Stadler, Z.; Klimstra, D.
Laboratory Investigation (2010)

Fulltext@MSK | Save

Grade progression of well differentiated neuroendocrine tumors (WDNETs) of the enteropancreatic system is distinct from poorly differentiated (PD) high grade neuroendocrine carcinomas (PDHGNECas)

Meeting Abstract

Tang, L. H.; Song, L.; Shia, J.; Vakiani, E.; Klimstra, D. S.
Modern Pathology (2010)

Fulltext@MSK | Save

Discordance between MSI-H histology and DNA mismatch repair (MMR) protein immunohistochemistry (IHC) in colorectal carcinoma of young patients: Frequency and clinical significance

Meeting Abstract

Shia, J.; Sempoux, C.; Tang, L.; Katabi, N.; Vakiani, E.; Guo, M.; Weiser, M.; Stadler, Z.; Klimstra, D.
Modern Pathology (2010)

Fulltext@MSK | Save

Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer